We're halfway between the April 2024 and August 2026 total solar eclipses: Here's why we're excited
When you buy through links on our articles, Future and its syndication partners may earn a commission.
There may be no total solar eclipse this year, but June 10, 2025, is a landmark event of sorts for eclipse chasers worldwide — the halfway point between the last and the next totalities.
It's 429 days — just over 14 months — since April 8, 2024's "Great American Eclipse" across North America and 429 days until the next total solar eclipse on August 12, 2026, over Greenland, Iceland and Spain.
Related: Eclipse at sea: Best cruises for the total solar eclipse 2026
For some devotees of what's often called "nature's greatest event," it's a moment to reflect on and relive a landmark eclipse now in the rearview mirror. About 50 million people experienced the last total solar eclipse in Mexico, 15 U.S. states and southeastern Canada. It was, as expected by many, an event with mixed weather. Texas, which had the best odds of a clear sky, had clouds to varying degrees, with the clearest weather in the supposedly cloudiest regions of Indiana, Ohio, upstate New York, Vermont, New Hampshire and Maine in the U.S., and Quebec and New Brunswick in Canada.
It was even cloudy over northern Mexico, but some had the right kind of sea legs. "We had to sail a considerable distance away from the coast to find a spot where it would be clear at eclipse time, and when the eclipse began in a clear blue sky, I got a rush of excitement as I realized we were going to see the entire spectacle," Rick Fienberg at the American Astronomical Society's Solar Eclipse Task Force, told Space.com. During totality, he noticed two parallel contrails in the sky close to the eclipse. "I realized they were from the two NASA research planes that were chasing totality about 40,000 feet above us [and] when I swung my binoculars to them, I could see the jets themselves," Fienberg continued.
Thoughts are now firmly fixed on the next total solar eclipse on August 12, 2026, which will see eclipse chasers head to the fjords of eastern Greenland in cruise ships, to remote parts of western Iceland and to northern Spain. The total solar eclipse on August 12, 2026, will have a maximum totality of 2 minutes and 18 seconds and be mainland Europe's first since 1999.
Eclipse cartographer Michael Zeiler at GreatAmericanEclipse.com and EclipseAtlas.com, who was clouded out in Texas, has plans in place. "I am in great anticipation of the return of nature's greatest sight," Zeiler told Space.com. "Total solar eclipses are guaranteed to take you to beautiful remote locations on Earth, and in 2026, Greenland is high on my bucket list."
Bucket list locations abound across the path. "I don't think the tourism industry realizes what they are about to experience because we haven't had a total solar eclipse visible from Iceland since the summer of 1954," Sævar Helgi Bragason, an astronomy and science communicator at Eclipse2026.is and IcelandAtNight.is told Space.com, who's been preparing since 2015. "I've spent the better part of last year and this year increasing awareness with the general public, giving talks and having countless meetings with municipalities, tour companies, even the minister of justice and members of the parliament," he says. "It's finally paying off [but] we still have a long way to go." He's hoping Iceland's unique charms appeal to eclipse chasers, adding: "You could witness the eclipse from a geothermal pool or surrounded by incredible volcanic landscapes — and Icelanders know how to throw a good party!"
For Spain, there's been a much longer wait for what will be a very special totality. "It's the first total solar eclipse visible from mainland Spain in over 120 years, and it's taking place in my home country," Dan Zafra, an astrophotographer at CaptureTheAtlas.com, told Space.com. "It's a rare opportunity not just for Spaniards but for eclipse chasers and photographers worldwide to witness totality in a stunning and accessible European setting."
As eclipse chasers on cruise ships in Greenland experience totality, the sun and moon will be about 25 degrees above the northwestern horizon. However, once the path has crossed northern Spain, it will be close to sunset. Fienberg will be on a cruise ship in the western Mediterranean Sea between the coast of mainland Spain and Mallorca, one of the Balearic Islands. "We'll have a little more than 1½ minutes of totality with the sun about 3½ degrees above the horizon just before sundown," said Fienberg. "Then we'll see the thin crescent sun appear to sink into the sea. The entire spectacle should be quite dramatic."
Since any one place on Earth experiences totality on average once every 36 years, according to NASA, eclipse chasing typically demands travel. "Once you've seen the dramatic beauty of a total solar eclipse, you might well get the bug to travel the world to see more," Zeiler said. "Life is short, and travel to far-away destinations will be so rewarding in so many ways."
The 2026 total solar eclipse will be followed one lunar year later on August 2, 2027, when a maximum totality of 6 minutes and 23 seconds will be seen from Egypt, with Spain, Morocco, Algeria, Tunisia, Libya, Egypt, Saudi Arabia, Yemen and Somalia also in the path. Another lunar year will see a 5-minute and 10-second totality on July 22, 2028, in Australia, with New Zealand getting totality close to sunset.
To the uninitiated, the passion of eclipse chasers leaves many confused. Perhaps that's because photos of totality typically fail to do the majesty of the event justice. Seeing the solar corona with the naked eye is a moment to savor, but there's much more to it than visuals." You don't just see a total solar eclipse. You feel it as the air cools and the wind changes speed and direction. You hear it in the cheers and cries of those around you and the sounds of insects and birds behaving as they do at sunset," said Fienberg. "It's among the most awesome experiences you can have on this planet — right up there with falling in love."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Newly Discovered Footprints Dramatically Re-date When Humans First Came to Americas
A new study published in the journal Science Advances confirms that the peopling of the Americas began much earlier than originally thought. Back in 2021, a series of footprints were discovered within the mud of a paleolake bed which had long ago dried up. A 2021 study hypothesized that the prints meant the arrival of settlers to North America occurred somewhere between 23,000 and 21,000 years earlier than previously believed. Now, the new study has confirmed that the footprints were made between 20,700 and 22,400 years ago. "It's a remarkably consistent record," explained lead author Vance Holliday, who was also a co-author on the initial study. "You get to the point where it's really hard to explain all this away. As I say in the paper, it would be serendipity in the extreme to have all these dates giving you a consistent picture that's in error.'Halliday undertook the study for a second time because there was some controversy over the use of ancient pollen and seeds to determine the footprints' age. For this new study, he and his researchers analyzed the mud itself. 'Mud never lies,' Halliday said, explaining that it always holds up to radiocarbon analysis. This most recent study makes the third paper and third laboratory to confirm the timeframe of the footprints' creation. 'It would be serendipity in the extreme to have all these dates giving you a consistent picture that's in error,' Halliday said. The discovery is particularly notable for its lack of artifacts, leading Halliday to posit that the footprints were left by nomadic hunter-gatherers trudging through the lake bed. 'These people live by their artifacts, and they were a long way from where they can acquire replacement material,' he explained. 'They're not just randomly losing artifacts. It's logical…If you're passing through, carrying your gear, you're not leaving it by chance.' The footprints predate the Clovis people, which have long been believed to be the oldest North American humans on record. 'When you stand there and see the prints, you understand they undermine everything you've learned. They're not gesture steps—they're a revolution in human arrival history,' Holliday said. Newly Discovered Footprints Dramatically Re-date When Humans First Came to Americas first appeared on Men's Journal on Jun 21, 2025
Yahoo
an hour ago
- Yahoo
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
These biotech companies have several catalysts ahead -- and in the past have soared on good news. They both offer innovative candidates that could result in game-changing treatments for patients. 10 stocks we like better than Viking Therapeutics › If you're looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening in these companies' labs, and in some cases, game-changing treatment candidates are approaching important milestones or even going over the finish line. As an investor in these companies, you can benefit as they report positive clinical trial news, score a regulatory approval, or start generating product revenue. Wall Street considers two candidates extremely compelling right now, with forecasts for potential gains of more than 80% and 200% in the coming 12 months. One of these players is working in the high-growth area of weight loss drugs, and the other candidate showed its strengths by winning the world's first-ever approval of a product based on CRISPR gene editing. Let's check out these two biotech stocks to buy before they skyrocket. Viking Therapeutics (NASDAQ: VKTX) soared early last year when it reported strong data from the phase 2 trial of its weight loss candidate, VK2735, but the stock has since given back those gains and is trading closer to the level it was at prior to that data announcement. Since, the company has continued to advance VK2735 in injectable form and a version in pill form, and demand for these sorts of drugs remains high -- these are two reasons to believe that Viking has the potential to take off again. And catalysts may be on the horizon. The drug works in a manner similar to Eli Lilly's blockbuster tirzepatide, sold under the names Mounjaro and Zepbound. These drugs interact with hormones involved in digestion and have helped people quickly and safely lose weight. Viking is beginning the phase 3 trial for injectable VK2735 in the second quarter and expects data from its phase 2 trial of the pill version in the second half. Any data announcements could result in big moves for the stock, as there is plenty of room for a new company to enter the weight loss drug market -- one forecast to approach $100 billion in a few years. Wall Street is optimistic about Viking's prospects, with the average price forecast predicting an increase of about 240% in the stock price from today's level. Of course, Viking depends heavily on the outcome of these trials, so some risk is involved -- but data have been strong, so growth investors may want to get in on Viking now to potentially post a big win later. CRISPR Therapeutics (NASDAQ: CRSP) stock surged in the year leading up to a major milestone: its first product approval. But since last year's launch of Casgevy, a gene-editing treatment for blood disorders, the stock has been on the decline. Sometimes, investors buy a stock well before the company wins approval or launches a product, then lock in gains after the good news lands -- and I think this is what's happened here. But what this does is offer us a chance to get in at a very good price on a promising company that could deliver fantastic news down the road. Casgevy, as a gene-editing treatment, requires a longer time to roll out than a pill or injection, as it includes several steps that happen over a period of months. The company recently said new patient initiations should increase "significantly" this year -- so there's reason to be optimistic about revenue growth ahead. CRISPR Therapeutics also recently reported positive phase 1 data for a gene editing candidate addressing the problem of high cholesterol. And the company expects to report data soon from a phase 1 trial of a candidate targeting patients with elevated levels of lipoprotein(a) -- a risk factor for cardiovascular events. These could represent huge markets for CRISPR Therapeutics if the candidates reach the finish line, and in the meantime, any potential positive news could boost the stock. The company also expects other trial updates in candidates for oncology and autoimmune diseases this year -- so this biotech's calendar is full of possible catalysts. Wall Street's average price forecast calls for an 84% gain for CRISPR Therapeutics from today's price -- if all goes well in clinical trials and Casgevy starts to show revenue growth, now could represent a golden buying opportunity for growth investors. Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CRISPR Therapeutics. The Motley Fool recommends Viking Therapeutics. The Motley Fool has a disclosure policy. 2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Elon Musk Makes Big Announcement About New Technology
The neurotechnology company co-founded by Elon Musk, Neuralink, is set for what could be world-changing human trials soon. Musk recently revealed that Neuralink will begin human trials for the company's first implants for vision within the next year. "In the next six to 12 months, we'll be doing our first implants for vision, where even if somebody is completely blind, we can write directly to the visual cortex," Musk said to Y Combinator on Thursday. Neuralink has already tested the implant on a monkey, and Musk says that the animal has had it for three years. He adds that the vision offered from the implant would be in low resolution at first, but will improve over time. "Long term, it'll be very high resolution and you'll be able to see multi-spectral wavelengths," Musk revealed. Musk said back in April that the vision of the people who use the implant "will exceed the best human eyes." The "Blindsight" implant will enable its users to see ultraviolet rays, infrared and radar "like a superpower situation," the Tesla CEO added. Neuralink's brain-computer interface (BCI) has already seen some success. The BCI was inserted into the brain of Noland Arbaugh, a paralyzed man who is now able to control computers with his thoughts thanks to the Musk Makes Big Announcement About New Technology first appeared on Men's Journal on Jun 21, 2025
